NCT02319005 · Interventional trial
ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
Overall registry status Completed
Phase 3
Conditions Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, Hereditary, Amyloidosis, Hereditary, Transthyretin-Related, Familial Transthyretin Cardiac Amyloidosis, Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
Delaware Valley sites
- Clinical Trial Site · Philadelphia, PA · Philadelphia County
- Clinical Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory